Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.032 | 0.7 |
mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |